FI875015A - Vaccin mot juverinflammation. - Google Patents

Vaccin mot juverinflammation. Download PDF

Info

Publication number
FI875015A
FI875015A FI875015A FI875015A FI875015A FI 875015 A FI875015 A FI 875015A FI 875015 A FI875015 A FI 875015A FI 875015 A FI875015 A FI 875015A FI 875015 A FI875015 A FI 875015A
Authority
FI
Finland
Prior art keywords
pct
aureus
juverinflammation
vaccin
mot
Prior art date
Application number
FI875015A
Other languages
English (en)
Other versions
FI875015A0 (fi
Inventor
Dennis Leslie Watson
Original Assignee
Commw Scient Ind Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org
Publication of FI875015A0 publication Critical patent/FI875015A0/fi
Publication of FI875015A publication Critical patent/FI875015A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/823Bacterial vaccine for bovine species, e.g. cattle
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/882Staphylococcus
    • Y10S435/883Staphylococcus aureus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI875015A 1985-05-13 1987-11-13 Vaccin mot juverinflammation. FI875015A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH052885 1985-05-13
PCT/AU1986/000134 WO1986006634A1 (en) 1985-05-13 1986-05-13 Mastitis vaccine

Publications (2)

Publication Number Publication Date
FI875015A0 FI875015A0 (fi) 1987-11-13
FI875015A true FI875015A (fi) 1987-11-13

Family

ID=3771099

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875015A FI875015A (fi) 1985-05-13 1987-11-13 Vaccin mot juverinflammation.

Country Status (13)

Country Link
US (2) US4840794A (fi)
EP (1) EP0259324B1 (fi)
JP (1) JPS62502839A (fi)
AT (1) ATE78403T1 (fi)
AU (1) AU589185B2 (fi)
CA (1) CA1338879C (fi)
DE (1) DE3686158T2 (fi)
DK (1) DK16087D0 (fi)
FI (1) FI875015A (fi)
IN (1) IN164864B (fi)
NO (1) NO169820C (fi)
NZ (1) NZ216119A (fi)
WO (1) WO1986006634A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8701451A (nl) * 1987-06-22 1989-01-16 Noordzee Lab N V Preparaat voor de bestrijding van mastitis bij herkauwers, werkwijze voor de bereiding daarvan en werkwijze voor het behandelen van herkauwers.
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines
WO1998005356A1 (en) * 1996-08-02 1998-02-12 Smithkline Beecham Corporation NOVEL FtsL
US5770208A (en) 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US6294177B1 (en) 1996-09-11 2001-09-25 Nabi Staphylococcus aureus antigen-containing whole cell vaccine
US20060062807A1 (en) 2001-12-11 2006-03-23 Marie-Anne Nahori Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
KR102061735B1 (ko) 2018-06-08 2020-01-02 대한민국(농림축산식품부 농림축산검역본부장) 황색포도알균 약독화 장독소 및 세포독소 재조합 단백질을 포함하는 백신 조성물
CN110387341A (zh) * 2019-07-17 2019-10-29 安徽赛德齐瑞生物科技有限公司 一种葡萄球菌培养液及其培养方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI40107C (fi) * 1961-05-15 1968-10-10 Parke Davis & Co Menetelmä uuden stafylokokkiantigeenin valmistamiseksi
US3535121A (en) * 1967-10-09 1970-10-20 Beatrice Foods Co Production of cream cheese flavor
GB1182555A (en) * 1967-10-16 1970-02-25 Saphar Lab Ltd An Anti-Mastitis Vaccine
US3625833A (en) * 1970-01-23 1971-12-07 James J Schaffer Process for producing antiviral substance from staphylococcus organisms
US4327082A (en) * 1979-07-12 1982-04-27 Adcock-Ingram Laboratories Limited Mastitis vaccination
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
AU8592982A (en) * 1981-07-14 1983-01-20 Commonwealth Scientific And Industrial Research Organisation Mastitis vaccine
US4762712A (en) * 1983-08-31 1988-08-09 Stolle Research & Development Corporation Anti-mastitis polyvalent vaccine, method of administration and method for production thereof
US4591499A (en) * 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis

Also Published As

Publication number Publication date
US4840794A (en) 1989-06-20
NO169820B (no) 1992-05-04
AU589185B2 (en) 1989-10-05
EP0259324B1 (en) 1992-07-22
NO870123D0 (no) 1987-01-13
DK16087A (da) 1987-01-13
WO1986006634A1 (en) 1986-11-20
IN164864B (fi) 1989-06-24
AU5861986A (en) 1986-12-04
FI875015A0 (fi) 1987-11-13
NO169820C (no) 1992-08-12
US5032522A (en) 1991-07-16
ATE78403T1 (de) 1992-08-15
EP0259324A4 (en) 1988-02-18
DK16087D0 (da) 1987-01-13
EP0259324A1 (en) 1988-03-16
DE3686158T2 (de) 1993-02-25
NZ216119A (en) 1989-01-06
CA1338879C (en) 1997-01-28
NO870123L (no) 1987-01-13
JPS62502839A (ja) 1987-11-12
DE3686158D1 (de) 1992-08-27

Similar Documents

Publication Publication Date Title
DE68924162D1 (de) Stressproteine und verwendungen dafür.
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
GR3031244T3 (en) A dosage form comprising an antigen and a salt form of an organic acid derivative of a sterol.
ZA91559B (en) Vaccines against cancer and infectious diseases
AU7176087A (en) Vaccine formulation
IL92374A0 (en) Skin test and test kit for aids
FI875015A (fi) Vaccin mot juverinflammation.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
DE69533693D1 (de) Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten
SE9003198L (sv) Fiskvaccin omfattande en virulent, invasiv bakterie
AU6006090A (en) A method of increasing adenosine excretion
DE69333588D1 (de) Verfahren zur verstärkung zellularer immunantworten
EP0414816A4 (en) Induction of tolerance to a foreign antigen
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
Haddad et al. Potency of two anti-rabies vaccines used for primary vaccination of dogs in Tunisia.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
UA7971C2 (uk) Спосіб профілактики післяпологових захворювань корів

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR